56371 The Signaling Axis of Tumor Suppressor LKB1 in Triple Negative Breast Cancer

ABSTRACT IMPACT: Identifying an important pathway in treatment resistant TNBC will allow for the future development of clinical therapeutics specific for this disease. OBJECTIVES/GOALS: Triple Negative Breast Cancer (TNBC) is a subtype of breast cancer characterized by negative expression of estroge...

Full description

Bibliographic Details
Main Authors: Khoa Nguyen, Madlin Alzoubi, Katherine Hebert, Thomas Cheng, Steven Elliott, Matthew Burow, Bridgette Collins-Burow
Format: Article
Language:English
Published: Cambridge University Press 2021-03-01
Series:Journal of Clinical and Translational Science
Online Access:https://www.cambridge.org/core/product/identifier/S2059866121004428/type/journal_article